Published in Pharmaceutics on December 22, 2016
Fiji: an open-source platform for biological-image analysis. Nat Methods (2012) 56.92
Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm (2000) 4.52
PLGA-based nanoparticles: an overview of biomedical applications. J Control Release (2012) 4.39
Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev (2012) 4.30
Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces (2009) 4.06
Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev (2008) 2.71
Seven challenges for nanomedicine. Nat Nanotechnol (2008) 2.59
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine (2011) 2.09
Cationic polymer based gene delivery systems. Pharm Res (2000) 1.98
Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev (2008) 1.77
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev (2011) 1.65
Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm (2008) 1.56
Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm (2005) 1.41
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces (2005) 1.37
Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev (2011) 1.36
Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci (2005) 1.35
Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm (2013) 1.03
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci (2005) 0.95
Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol (2008) 0.94
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev (2012) 0.94
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm (2007) 0.93
Self-assembled and nanostructured siRNA delivery systems. Pharm Res (2011) 0.86
Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization. Biomacromolecules (2007) 0.85
The nanomedicine revolution: part 1: emerging concepts. P T (2012) 0.83
Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications. J Biomed Mater Res A (2012) 0.83
Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation. Eur J Pharm Biopharm (2010) 0.82
Novel alginate coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of BSA. J Mater Sci Mater Med (2013) 0.81
Stable and pH-sensitive nanogels prepared by self-assembly of chitosan and ovalbumin. Langmuir (2006) 0.81
Cell response to the exposure to chitosan-TPP//alginate nanogels. Biomacromolecules (2011) 0.80
Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles. Curr Pharm Des (2015) 0.80
Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm (2010) 0.80
Synthesis and structural characterization of chitosan nanogels. Langmuir (2009) 0.79
Preparation of nanoscale pulmonary drug delivery formulations by spray drying. Adv Exp Med Biol (2014) 0.79
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release (2011) 0.79
Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery. AAPS PharmSciTech (2014) 0.78
Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach. Curr Pharm Des (2014) 0.77
Hyaluronic Acid-Based Nanogels Produced by Microfluidics-Facilitated Self-Assembly Improves the Safety Profile of the Cationic Host Defense Peptide Novicidin. Pharm Res (2015) 0.77